Functional and structural alterations induced by copper in xanthine oxidase
Mahnaz Hadizadeh1, Ezzatollah Keyhani, Jacqueline Keyhani
1Institute of Biochemistry and Biophysics, University of Tehran, 13145 Tehran, Iran.
Acta Biochimica Et Biophysica Sinica
|July 7, 2009
Summary
Copper (Cu2+) can alter xanthine oxidase (XO) activity and structure, influencing purine metabolism. Its binding to XO reveals complex regulatory mechanisms potentially impacting heart health.
Area of Science:
- Biochemistry
- Enzymology
- Metalloprotein chemistry
Background:
- Xanthine oxidase (XO) is crucial in purine metabolism and generates reactive oxygen species linked to vascular injury and heart failure.
- Understanding enzyme-metal interactions is vital for elucidating biological regulatory pathways.
Purpose of the Study:
- To investigate the in vitro effects of copper (Cu2+) on xanthine oxidase (XO) activity and structure.
- To characterize the binding interactions between Cu2+ and XO and their impact on enzyme function.
Main Methods:
- Enzyme activity assays under steady-state kinetics.
- Spectroscopic analyses including electronic absorption, fluorescence, and circular dichroism.
- Kinetic analysis to determine binding affinities (dissociation constants).
Main Results:
- Cu2+ exhibited concentration- and time-dependent effects, either stimulating or inhibiting XO activity.
- Cu2+ binding induced structural changes in XO, affecting electronic, fluorescence, and secondary/tertiary structures.
- High-affinity Cu2+ binding sites impacted molybdenum and flavin adenine dinucleotide centers, while low-affinity sites affected all reactive centers (including FeS).
Conclusions:
- Copper ions play a significant role in regulating XO activity through distinct binding interactions.
- Structural modifications induced by Cu2+ binding correlate with altered enzyme kinetics and function.
- These findings highlight copper's potential as a modulator of XO in biological systems.
Related Concept Videos
01:43Electron Transport Chain: Complex III and IV
During the electron transport chain, electrons from NADH and FADH2 are first transferred to complexes I and II, respectively. These two complexes then transfer the electrons to ubiquinol, which carries them further to complex III. Complex III passes the electrons across the intermembrane space to Cyt c, which carries them further to complex IV. Complex IV donates electrons to oxygen and reduces it to water. As electrons pass through complexes I, III, and IV, the energy released aids the pumping...
01:17Oxidation of Phenols to Quinones
In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox property is crucial in...
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox property is crucial in...
01:30The Electron Transport Chain
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
01:25Bioactivation and Tissue Toxicity
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
01:19Phase I Oxidative Reactions: Overview
Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
01:19Phase II Reactions: Miscellaneous Conjugation Reactions
Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...